< Back to latest news & events

Event

Seminar: Strategies and updates on patenting inventions relating to personalised medicine in Europe and the US – Basel

October 2019

Event date: 17th October 2019

HGF is hosting a seminar in Der Teufelhof Basel on Thursday 17th October at 6pm. Partner Dr Leena Contarino and Patent Director Dr Laurence Gainey will consider strategies for patenting inventions in Europe and the US.

Targeted intervention (also known as personalised medicine or precision medicine) is a rapidly evolving field of medicine in which treatments are selected based on the detection of disease markers in individual patients. This enables doctors to prescribe treatment regimens that are tailored to individual patients’ medical needs.

Targeted intervention is already well established modern oncology where new drugs are now often approved together with companion diagnostics used to identify particular markers or genetic mutations in a patient. It is likely that targeted intervention will also become a feature in other therapy areas as the technology evolves. Patenting and enforcing patents covering personalised medicine inventions can be challenging, most notably in the USA.

This seminar will consider strategies for patenting these inventions in Europe and the US, including an update on the evolving situation in the US such as: legislative efforts, USPTO updated guidance and recent court cases such as Athena Diagnostics, Inc. v. Mayo Collaborative Services, LLC (Fed. Cir. July 3, 2019).

To register please email [email protected].

Latest updates

Gender diversity at the UPC

In Europe, women remain grossly under-represented in research and innovation. A recent study by the European Patent Office (EPO) found that only 13.2% of inventors in Europe are women. The …

Read article
Event - 29th November 2022

LSPN Europe 2022

HGF is a silver sponsor of LSPN Europe 2022 on 29th November in London. This event will explore some of the biggest challenges facing the Life Sciences Patent Community right now …

Event details

Oral Proceedings by videoconference (VICO) in oppositions proceedings to become permanent

The pilot project for oral proceedings in opposition proceedings by video conference (VICO) started during the pandemic and has received positive feedback.[1] The President of the EPO has therefore declared …

Read article
Event - 9th December 2022

Health Tech Conference 2022

HGF is a premium sponsor of the pro-manchester Health Tech conference on Friday 9th December. This conference looks at exploring what new and innovative ideas have been developed in the …

Event details

Comparing the value of European vs Unitary Patent Validation

The EPO’s European patent system is on the brink of the biggest change in a generation – from 2023 it is expected that a new unitary patent (UP) will become …

Read article

EPO sets start of Unitary Patent transitional measures as 1 January 2023

The EPO has announced that it intends to adjust the start date of its transitional measures for Unitary Patents (UP) to 1 January 2023. From that date, applicants who have …

Read article